Emerging Alzheimer's disease therapies: Focusing on the future

Neurobiology of Aging

Volumn 23, Issue 6, 2002, Pages 985-990

  Trojanowski, John Q ^a   Lieberburg, Ivan ^f   Lemere, Cynthia ^b   Gandy, Sam ^f   Bush, Ashley ^b   Frangione, Blas ^c   Citron, Martin ^f   Li, Yue Ming ^f   Lee, Virginia M Y ^d   Sisodia, Sangram ^e   Clark, Christopher ^d   Karlawish, Jason ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f University of Chicago ^*

Author keywords

A ; Brain amyloidosis; Drug discovery; Neurodegenerative diseases

Indexed keywords

ALPHA SYNUCLEIN; CLIOQUINOL; PEPTIDE; PEPTIDE FRAGMENT; PROTEIN PRECURSOR; VACCINE; AMYLOID; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; BACE1 PROTEIN, MOUSE; ESTROGEN; LIGAND; PROTEINASE; SECRETASE; TESTOSTERONE;

ALZHEIMER DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; IMMUNOTHERAPY; NERVE CELL; NONHUMAN; PATHOLOGY; PRECURSOR; PRIORITY JOURNAL; SENILE PLAQUE; UNITED STATES; AGED; AMYLOIDOSIS; ANIMAL; BLOOD; DRUG EFFECT; FEMALE; FORECASTING; GERIATRICS; HORMONE SUBSTITUTION; MALE; METABOLISM; METHODOLOGY; MOUSE;

ALZHEIMER DISEASE; ANIMAL; FORECASTING; HUMAN; AGED; AMYLOID; AMYLOID PRECURSOR PROTEIN SECRETASES; AMYLOIDOSIS; ANIMALS; ASPARTIC ENDOPEPTIDASES; ENDOPEPTIDASES; ESTROGENS; FEMALE; GERIATRICS; HORMONE REPLACEMENT THERAPY; HUMANS; IMMUNOTHERAPY; LIGANDS; MALE; MICE; TESTOSTERONE;

EID: 0036827419     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00123-9     Document Type: Conference Paper

References (7)

1. Galvin J.E., Lee V.M.-Y., Trojanowski J.Q. Synucleinopathies: Clinical and pathological implications. Arch. Neurol. 58:2001;186-190.
2. Irizarry M.C., Hyman B.T. Alzheimer disease therapeutics. J. Neuropath. Exper. Neurol. 60:2001;923-928.
3. Mayeux R., Sano M. Treatment of Alzheimner's disease. New Engl. J. Med. 341:1999;1670-1679.
4. Morris J.C., Ernesto C., Schafer K., Coats M., Leon S., Sano M.et al. Clinical dementia rating training and reliability in multicenter studies: The Alzheimer's disease cooperative study experience. Neurol. 48:1997;1508-1510.
5. Sano M., Ernesto C., Klauber M.R., Schafer K., Woodbury P., Thomas R.et al. Ratinale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes Alzheimer's disease cooperative study. Alzheimer Dis. Assoc. Disord. 10:1996;132-140.
6. Trojanowski J.Q., Lee V.M.-Y. "Fatal attractions" of proteins: A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann. New York Acad. Sci. 924:2000;62-67.
7. Trojanowski J.Q. Alzheimer's disease centers and the dementias of aging program of the national institute on aging: A brief overview. J. Alzheimer's Dis. 3:2001;249-251.